Anesth Analg 2006;103:1322-1326
© 2006 International Anesthesia Research Society
doi: 10.1213/01.ane.0000242515.03653.bb
ANALGESIA
Local Anesthetic-Induced Cardiac Toxicity: A Survey of Contemporary Practice Strategies Among Academic Anesthesiology Departments
William Corcoran, MD*,
John Butterworth, MD ,
Robert S. Weller, MD*,
Jonathan C. Beck, MD*,
J. C. Gerancher, MD*,
Timothy T. Houle, PhD*, and
Leanne Groban, MD
From the *Department of Anesthesiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina; and Department of Anesthesia, Indiana University School of Medicine, Indianapolis, Indiana.
Address correspondence to Leanne Groban, MD, Department of Anesthesiology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1009. Address e-mail to lgroban{at}wfubmc.edu. Reprints will not be available from the author.
Abstract
Though new local anesthetics (LA), effective test-dosing, and new regional anesthetic techniques may have improved the safety of regional anesthesia, the optimal management plan for LA-induced cardiac toxicity remains uncertain. Accordingly, we evaluated current approaches to LA cardiotoxicity among academic anesthesiology departments in the United States. A 19-question survey regarding regional anesthesia practices and approaches to LA cardiac toxicity was sent to the 135 academic anesthesiology departments listed by the Society of Academic Anesthesiology Chairs-Association of Anesthesiology Program Directors. Ninety-one anonymously completed questionnaires were returned, at a response rate of 67%. The respondents were categorized into groups according to the number of peripheral nerve blocks (PNBs) performed each month: >70 PNBs (38%), 5170 PNBs (13%), 3150 PNBs (20%), 1130 PNBs (23%), and <10 PNBs (6%). Anesthesia practices administering >70 PNBs were 1.7-times more likely to use ropivacaine (NS), 3.9-times more likely to consider lipid emulsion infusions for resuscitation (P = 0.008), and equally as likely to have an established plan for use of invasive mechanical cardiopulmonary support in the event of LA cardiotoxicity (NS) than low-PNB volume centers. We conclude that there are differences in the management and preparedness for treatment of LA toxicity among institutions, but the safety implications of these differences are undetermined.
This article has been cited by other articles:

|
 |

|
 |
 
P. C. Marwick, A. I. Levin, and A. R. Coetzee
Recurrence of Cardiotoxicity After Lipid Rescue from Bupivacaine-Induced Cardiac Arrest
Anesth. Analg.,
April 1, 2009;
108(4):
1344 - 1346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Rowlingson
Lipid Rescue: A Step Forward in Patient Safety? Likely So!
Anesth. Analg.,
May 1, 2008;
106(5):
1333 - 1336.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. L. Weinberg
Lipid Infusion Therapy: Translation to Clinical Practice
Anesth. Analg.,
May 1, 2008;
106(5):
1340 - 1342.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L Corman and S. J Skledar
Use of Lipid Emulsion to Reverse Local Anesthetic-Induced Toxicity
Ann. Pharmacother.,
November 1, 2007;
41(11):
1873 - 1877.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Weinberg and T. VadeBoncouer
Drug Interaction or Drug Overdose? Supercaine Revisited
Anesth. Analg.,
August 1, 2007;
105(2):
544 - 545.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Groban, J. C. Gerancher, R. S. Weller, and J. Butterworth
Antidotes to Anesthetic Catastrophe: Lipid Emulsion and Dantrolene
Anesth. Analg.,
July 1, 2007;
105(1):
284 - 284.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Picard, S. Ward, and T. Meek
Antidotes to Anesthetic Catastrophe: Lipid Emulsion and Dantrolene
Anesth. Analg.,
July 1, 2007;
105(1):
283 - 284.
[Full Text]
[PDF]
|
 |
|
|